Hytrin 10 (Terazosin Hydrochloride Dihydrate)

Terazosin works by selectively blocking alpha‑1 adrenergic receptors on blood vessels and in the prostate. This blockade prevents norepinephrine‑induced constriction, causing blood vessels to dilate and reducing peripheral resistance. In the prostate, it relaxes smooth muscle, easing urinary passage.

The dosage of Hytrin 10 is individualized by a qualified prescriber based on the patient’s medical condition, response to therapy, and other medications. Only a healthcare professional can determine the appropriate starting dose and any subsequent adjustments.

Safety data for terazosin in pregnancy and lactation are limited. Because potential risks cannot be excluded, the product should generally be avoided unless the prescriber determines that the benefit outweighs the possible harm to the fetus or infant.

To request Hytrin 10, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hytrin 10 (terazosin) shares the same class mechanism as other alpha‑1 antagonists such as doxazosin and prazosin. All lower blood pressure and improve urinary flow, but individual agents differ in dosing frequency, half‑life and side‑effect profiles. Choice of therapy is guided by clinical response, tolerability and physician preference.

Store Hytrin 10 at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not store in a refrigerator or freezer.

Hytrin 10 is taken orally, usually with a full glass of water. It may be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and whether the dose should be taken in the morning or evening.

Serious adverse events include severe hypotension, syncope, priapism and anaphylactic reactions. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, prolonged painful erection, or signs of an allergic reaction such as swelling, rash or difficulty breathing.

Hytrin 10 is contraindicated in patients with known hypersensitivity to terazosin or any component of the formulation. Caution is advised for individuals with severe orthostatic hypotension, recent myocardial infarction, or those taking certain interacting medications such as other alpha‑1 blockers or potent CYP3A4 inhibitors.